PowerPoint presentation on ECMO (Extracorporeal Membrane Oxygenation). Part 2 focuses on Monitoring ECMO patients
Ventilatory strategies, Sedation and pain control, Weaning, Complications and recent advances in ECMO. For better understanding please have a look at ECMO part 1 before going through part 2.
A brief yet comprehensive coverage of ICU role in ECMO cases. Presentation has been prepared in order to help ICU fellows and registrars to understand the importance of their role and to know necessary actions they have to take in case of need.
A brief yet comprehensive coverage of ICU role in ECMO cases. Presentation has been prepared in order to help ICU fellows and registrars to understand the importance of their role and to know necessary actions they have to take in case of need.
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
Point of critical care Ultrasound play a pivotal role in management of critically ill patients admitted in ICU . Its usage in this regard is ever growing . Here we discus about pearls and pitfalls of POCUS in Intensive care medicine.
Peter McCanny is part of the LearnECMO team. In this podcast he explains some of the background and history of ECMO CPR, what evidence there is to support its use and where we're heading in the future.
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
Point of critical care Ultrasound play a pivotal role in management of critically ill patients admitted in ICU . Its usage in this regard is ever growing . Here we discus about pearls and pitfalls of POCUS in Intensive care medicine.
Peter McCanny is part of the LearnECMO team. In this podcast he explains some of the background and history of ECMO CPR, what evidence there is to support its use and where we're heading in the future.
How is COPD and Nutrition Overlapped and Affecting Each Other
How to Solve the Problem as a Part of Pulmonary Rehabilitation
The Presentation is Discussing these items in the form of Problem Solving
What are the main sleeping disorders and what are the sleeping disorders related to respiratory system ? how to deal with it and how to diagnose and treat?
Early Enteral Nutrition in Critically Ill Patients is the best for helping early recovery, decreasing hospital stay and decreasing malnutrition in ICU
How? When? Formulas used? Access forms?
PowerPoint presentation on the topic HRCT Chest. This presentation is divided into 5 different parts. 1)Introduction to HRCT chest 2)Technichal aspects of HRCT 3) Relevant anatomy for HRCT interpretation 4)Pattern of lung disease in HRCT 5)HRCT pattern in various ILD’s
PowerPoint presentation describing various aspects of Pulmonary Hypertension. Please mail me your feedback on this presentation to following Email ID: tinkujoseph2010@gmail.com.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Contents in ECMO part 1
What is ECMO ?
Evolution of ECMO
Various Trials
Types
Indications
Veno-venous V/S veno-Arterial
ECMO.
Cannulation and Circuit
3. Contents in ECMO part 2
Monitoring ECMO patients
Ventilatory strategies
Sedation and pain control
Weaning
Complications
Recent advances
5. Who comprises the ideal team?
Two intensivists (ECMO intensivist)
and/or cardiothoracic surgeons:
cannulation
One Medical Officer: monitor cannula
position by ECHO
One Medical Officer: clinical
management
Perfusionist: ECMO priming and
maintenance
Respiratory Therapist: lung protective
management, ventilator settings
6. • Nurses:
– assists in the procedure.
– supports clinical
management.
– ONGOING CARE FOR
ECMO PATIENT
• Radiologic Technician
Who comprises the ideal team?
7. Protocol for initiation and stabilization
of ECMO
1) Check the cannula site
2) Check all ports
3) Connect the pressure tubing to the pressure line
4) Connect the flow sensor to the flow meter
5)Note patient vitals (prior to starting ECMO)
6) Send pre –ECMO investigations: ABG, VBG, CBC
8. Protocol for initiation and stabilization
of ECMO
7) Confirm bolus dose of heparin is given
8) Confirm the availability of blood and blood products
9) Check for ACT machine
10) Request Xray plate from radiology and place under
patient.
11) Confirm circuit is primed properly
9. Protocol for initiation and stabilization
of ECMO
12) Connect Venous end of circuit to venous cannula
13) Connect arterial end to artery (VA) or jugular vein
(VV)
14) Recheck everything
15) Open arterial clamp, clamp the bridge and then
open venous clamp for roller pump.
16) Before starting ECMO start centrifugal pump to
provide forward flow
10. Protocol for initiation and stabilization
of ECMO
17) start the pump with flow of 20 ml/kg/min and
gradually increase the flow after every 5-10 mins by
10ml/kg/min up to the desired flow.
18) Adjust gas flow to blood flow ratio 0-5:1 and start
FiO2 of 21% and slowly increase to 100%.
19) Check for the color of venous and arterial blood.
11. Protocol for initiation and stabilization
of ECMO
20)Attach heater cooler unit to oxygenator and adjust
temp to 37c
21) Check vitals again
22) Check pre pump, pre and post oxygenator
pressures.
23) Once desired flow is achieved come down on
ventilator settings to baseline.
24) Monitor MAP-: 60-70mmhg
25) Reduce inotropes
26) If BP is high use NTG
12. 27) Check ACT & ABG after one hour of starting ECMO
28) If ACT is around 200 seconds then start with
heparin infusion @ 20 units/kg/hr
29) <160 -: bolus dose of heparin
30) >200 -: decrease heparin dose
31) Monitor ABG -: Adjust ECMO settings
Protocol for initiation and stabilization
of ECMO
14. Nursing Actions
Maintain strict infection control.
Restrict access to essential personnel.
Remove unnecessary invasive lines.
Ensure that all required invasive access are
present, eg. NGT, core temp probe.
Secure ET tube to maintain access during
procedure maintaining the sterile field.
15. Ensure crash trolley in close proximity
Ensure fecal softeners as prescribed.
Prepare and position patient. Place appropriate
mattress on bed.
Clip hair on the proposed site with electric razor.
Move the bed so the ECHO machine, ECMO trolley
and sterile field can be positioned
Nursing Actions
17. Dressing the cannula
Only if there is significant exudates
or if not intact or secured.
Required two nurses for dressing.
Dressing changes preferable in day
shift.
Pull the dressing off towards the
insertion site.
18. Blood Works and Diagnostics
Ensure current crossmatch PRBCs are
available.
Daily electrolytes, Mg and LFT.
CBC BD and as sos. PLATELET COUNT
Daily blood cultures during spike of fever
or ideally beginning at 5th day of
therapy.
Pre and post oxygenator ABG c/o
perfusionist.
ACT every 2 hours x 24 hours.
APTT every 6 hours, target 55-75 s or as
specified by intensivist.
19. Ventilatory strategies
ELSO GUIDELINES FOR RESPIRATORY SUPPORT:
Indication:
“In hypoxic respiratory failure due to any cause ECLS
should be considered when the risk of mortality is
50% or greater and is indicated when the risk of 80%
or greater.
20. Ventilatory strategies
A) 50% mortality risk can be identified by PaO2/FiO2
<150 on FiO2 >90% and/or Murray score 2 to 3.
(Consider ECMO)
B) 80% mortality risk can be identified by a PaO2/FiO2
<80 on FiO2 >90% and Murray score 3 to 4. (ECMO
Indicated)
21.
22. 2) Co2 retention due to asthma or permissive
hypercapnia with a PaCo2 >80 or inability to achieve
safe inflation pressure (Pplat <30cmH2O).
3) Severe air leak syndromes.
Ventilatory strategies
23. Goal -: to let the lung rest and yet not allow total
lung collapse.
ECMO provides adequate gas exchange.
Reduces chances of VILI.
Patient may not require intubation at times.
Low tidal volume required
Less sedation
Early rehabilitation.
Ventilatory strategies
24.
25.
26. Sedation and Pain control
Goal:
Keep the patient comfortable
with minimal sedation
Daily interruption-give awake
cycle
Avoid muscle relaxant as far as
possible.
27. Sedation and Pain control
Indications for sedation:
To relieve pain and anxiety
Decrease O2 consumption and CO2 production
Prevent patient from removing lines
Patient ventilator asynchrony
To give normal sleep pattern at night
Before any procedure
28. Sedation and Pain control
Indications for muscle relaxants:
Patient ventilator asynchrony
When patient movement interferes
with venous return
To prevent accidental decannulation
– due to excessive patient
movement
29.
30. In awake patient:
Better lymphatic drainage from the lungs with the
spontaneous breathing as compared to positive
pressure ventilation.
Lesser haemodynamic effect, lesser ventilator
requirements and peak pressures.
Better infection control
33. Weaning
After giving adequate rest to the
organ.
When they show signs of
improvement.
34. Criteria for weaning trial
RESPIRATORY:
CXR is improving
Lung compliance improve: compliance >0.5 mL/kg
ABG- on rest ventilator setting with moderate ECMO
support
PaO2 >60mmhg
PaCo2 <50mmhg
PH >7.35
Successful 100% oxygen challenge test.
35. CARDIAC:
HR <120/min
Systolic BP >90mmhg or pulse pressure >40mmhg,
mean arterial pressure >70mmhg
CVP <12 mmhg
Urine output > 0.5 cc/kg/hr (ARF case excluded)
Good tissue perfusion as revealed by blood lactate
<3 mol/L and SVO2 >65%
CXR improving
2 D Echo-: EF >40%
Criteria for weaning trial
36. Method of weaning- VA
Slow gradual process
Moderate ECMO & moderate ventilatory settings
(FIO2 <40%, PEEP 8-10)
Method 1
Upgrade ventilatory settings and start inotropes if
required.
Gradually reduce blood flow (10 ml/kg/hr). Continue
till minimum flow
Heparin should be maintained to prevent circuit
clogging.
37. Method 2:
Withdraw a total ECMO support for few minutes and
observe parameters
If patient tolerates gradually period of off ECMO is
increased.
Patient can tolerate >2 hours off ECMO, consider
decannulation
Method of weaning-VA
38. 1) Decreasing pump flow (20 ml/kg/min) -: Not used
now a days.
2)Oxygen supply is reduced. More simple way.
FiO2 is reduced by 5% every 30 minutes. Ventilator
setting is upgraded.
FiO2 is 21% then sweep gas flow is being reduced by
10% every 30 minutes
Alternate method: Only sweep gas reduced. FiO2
unchanged.
Method of weaning-VV
39. Rush weaning
Forced to remove ECMO even when higher degree of
support is required
Indications:
Massive bleeding
Severe haemolysis
Worsening intracranial bleed
Infection related to cannula
Risk of continuing ECMO is more than risk of discontinuing ECMO
40. Decannulation
Ensure two medical staff are involved in the removal of
the cannulas, while a third medical staff clinically
manage the patient.
Coordinate with perfusionist and respiratory technician
about the plans.
Ensure that direct pressure is applied on the insertion
site for at least 20 minutes and the ECMO intensivist
will remain with the patient until hemostasis achieved.
Coordinate with intensivist about the need for sedation
and pain medication before the procedure.
Carry out successive Doppler assessment of the
decannulated limbs after catheter removal.
42. Bleeding
Hourly cannula site assessment.
Monitor clotting time, Hb, platelets.
Ensure access sites are stabilized. Do
not dislodge clots directly from
wounds or insertion sites.
Maintain enteral feeding if tolerated;
ulcer prophylaxis.
Report blood loss.
Ensure current crossmatched PRBC.
Give blood products as ordered.
43. Hemolysis
Monitor the lab results( CBC, U/E and urine)
Hourly assessment for movement(kinking) of the
access cannula
Hourly assessment of the temperature of the heat
exchanger
62. When God is going to do
something wonderful he
begins with a difficulty…….
If he is going to do something
very wonderful.
He begins with a……..
ECMO Machine
(Quote by an ECMO survivor)